City of Hope’s comprehensive CAR T program is addressing some of the hardest-to-treat cancers by accelerating innovative clinical research approaches. Currently, we have many ongoing trials with additional trials expected to open in the new year.
For all CAR T Inquiries (patient, physician, clinical trials)
833-310-CART (2278)
Media Inquiries
[email protected]

Ongoing trials

Ongoing CAR T clinical research initiated at City of Hope includes trials in:

Solid tumors

Blood cancers

Partner trials

City of Hope is partnering with global biopharmaceutical companies on the following ongoing trials:

Solid tumors

​Blood cancers

New trials

New clinical trials initiated at City of Hope opening in the coming months and in the coming year include:

Blood cancers

  • The rare disease amyloidosis

Preclinical CAR T research

City of Hope is also conducting preclinical CAR T research in solid tumors for ovarian, head and neck, cervical and pancreatic cancers.